These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37003156)

  • 1. Reduced P-glycoprotein recognition of a radioiodine-labeled phosphonium cation by stilbenylation for mitochondrial membrane potential based-imaging.
    Suzuki C; Sakai T; Magata Y
    Bioorg Med Chem; 2023 Apr; 84():117260. PubMed ID: 37003156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
    Hirayama C; Watanabe H; Nakashima R; Nanbu T; Hamada A; Kuniyasu A; Nakayama H; Kawaguchi T; Saito H
    Pharm Res; 2008 Apr; 25(4):827-35. PubMed ID: 17934801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of P-glycoprotein on intracellular drug concentration in peripheral blood mononuclear cells and K562 cells.
    Ito K; Naoi M; Nishiyama K; Kudo T; Tsuda Y; MacLean C; Ishiguro N
    Drug Metab Pharmacokinet; 2023 Apr; 49():100487. PubMed ID: 36724603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein.
    Fujita Y; Noguchi K; Suzuki T; Katayama K; Sugimoto Y
    BMC Res Notes; 2013 Nov; 6():445. PubMed ID: 24196382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
    Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
    Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of P-glycoprotein and its inhibitors on apoptosis in K562 cells.
    Zu Y; Yang Z; Tang S; Han Y; Ma J
    Molecules; 2014 Aug; 19(9):13061-75. PubMed ID: 25157469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
    Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.
    Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ
    Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial localization of P-glycoprotein and peptide transporters in corneal epithelial cells--novel strategies for intracellular drug targeting.
    Barot M; Gokulgandhi MR; Pal D; Mitra AK
    Exp Eye Res; 2013 Jan; 106():47-54. PubMed ID: 23116562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of radioiodinated lipophilic cationic compounds for myocardial imaging.
    Sakai T; Saito Y; Takashima M; Ogawa M; Magata Y
    Nucl Med Biol; 2015 May; 42(5):482-487. PubMed ID: 25735221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers.
    Bentz J; Ellens H
    Methods Mol Biol; 2021; 2342():737-763. PubMed ID: 34272715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
    Wang Z; Zhou N; Zhao J; Zhang X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct interaction of nilotinib and imatinib with P-Glycoprotein in intracellular accumulation and cytotoxicity in CML Cell Line K562 cells.
    Yamakawa Y; Hamada A; Uchida T; Sato D; Yuki M; Hayashi M; Kawaguchi T; Saito H
    Biol Pharm Bull; 2014; 37(8):1330-5. PubMed ID: 25087954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Iodinated Radiographic Contrast Media on Multidrug-resistant K562/Dox Cells: Mitochondria Impairment and P-glycoprotein Inhibition.
    Supawat B; Udomtanakunchai C; Kothan S; Tungjai M
    Cell Biochem Biophys; 2019 Jun; 77(2):157-163. PubMed ID: 30924055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can P-glycoprotein mediate resistance to nilotinib in human leukaemia cells?
    Kosztyu P; Dolezel P; Mlejnek P
    Pharmacol Res; 2013 Jan; 67(1):79-83. PubMed ID: 23103446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Drug Modulator Diarylheptanoid (
    Viriyaadhammaa N; Duangmano S; Saiai A; Tungjai M; Dejkriengkraikul P; Tima S; Chiampanichayakul S; Krise J; Anuchapreeda S
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012254
    [No Abstract]   [Full Text] [Related]  

  • 19. Epifriedelanol enhances adriamycin-induced cytotoxicity towards K562/ADM cells by down regulating of P-gp and MRP2.
    Li Y; Liao Z; Wei X; Xiao X; Hu J
    Xenobiotica; 2022 Apr; 52(4):389-396. PubMed ID: 35582915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
    Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
    Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.